Organovo Holdings Inc (ONVO)

2.73
0.01 0.55
NASDAQ : Health Care
Prev Close 2.71
Open 2.71
Day Low/High 2.67 / 2.74
52 Wk Low/High 2.48 / 4.99
Volume 566.49K
Avg Volume 906.00K
Exchange NASDAQ
Shares Outstanding 104.58M
Market Cap 279.24M
EPS -0.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Biotech Movers: Intra-Cellular Therapies, Organovo, Acorda

Biotech Movers: Intra-Cellular Therapies, Organovo, Acorda

Intra-Cellular Therapies, Organovo Holdings and Acorda Therapeutics were among the biotech stock movers in premarket trading on Monday.

Biotech Movers: Organovo, Endo, Omeros

Biotech Movers: Organovo, Endo, Omeros

Organovo, Endo and Omeros were among the biotech stock moves in premarket trading on Thursday.

Biotech Movers: Neurocrine Biosciences Leaps on Drug Approval, Synergy Pharma Issued Three Patents

Biotech Movers: Neurocrine Biosciences Leaps on Drug Approval, Synergy Pharma Issued Three Patents

The company's shares were up 24% ahead of market's open on an FDA approval.

Organovo Announces CEO Transition

Organovo Publishes Data Describing Physiology Of 3D Bioprinted Human Kidney Tissues For Drug Toxicity Testing

Organovo also celebrates positive review of Organovo's 3D bioprinted human liver tissue from industry leaders

Immunomedics, Seattle Genetics Lead Biotech Movers on Deal News

Immunomedics, Seattle Genetics Lead Biotech Movers on Deal News

The companies inked a $250 million deal on Friday that could be worth up to $2 billion, thanks to milestone payments.

Biotech Premarket Movers: Pacira, Clearside Biomedical and Organovo

Biotech Premarket Movers: Pacira, Clearside Biomedical and Organovo

Pacira Pharmaceuticals, Clearside Biomedical and Organovo Holdings are among the premarket biotech movers on Wednesday.

Biotech Premarket Movers: Amicus Therapeutics, Nantkwest and Organovo

Biotech Premarket Movers: Amicus Therapeutics, Nantkwest and Organovo

Amicus Therapeutics, Nantkwest and Organovo are among the premarket biotech movers on Tuesday.

Interesting ONVO Put And Call Options For August 2017

Interesting ONVO Put And Call Options For August 2017

Investors in Organovo Holdings Inc saw new options begin trading this week, for the August 2017 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Organovo Presents First Preclinical Data On 3D Bioprinted Human Liver Tissues At TERMIS-Americas Meeting

Organovo Presents First Preclinical Data On 3D Bioprinted Human Liver Tissues At TERMIS-Americas Meeting

Results demonstrate clinical promise for bioprinted tissues

Short Interest Moves 32.3% Lower For ONVO

Short Interest Moves 32.3% Lower For ONVO

The most recent short interest data has been released for the 10/31/2016 settlement date, which shows a 4,796,096 share decrease in total short interest for Organovo Holdings Inc , to 10,067,667, a decrease of 32.27% since 10/14/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Interesting ONVO Call Options For December 16th

Interesting ONVO Call Options For December 16th

Investors in Organovo Holdings Inc saw new options become available today, for the December 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ONVO options chain for the new December 16th contracts and identified the following call contract of particular interest.